EUROAPI’s Board of Directors Proposes Mattias Perjos as Independent Director 12th January 2023
The Board of Directors of EUROAPI proposes the ratification of the appointment by co-optation of a new independent director, Mattias Perjos, as of January 11, 2023. Corinne Le Goff, after serving as an independent member on the Board of Directors since May 6, 2022, has resigned from her directorship as of January 11, 2023. Corinne Le Goff has been appointed as President and Chief Executive Officer of Imunon.
Mattias Perjos is currently President and Chief Executive Officer of Getinge, a listed company on the Stockholm Stock Exchange, which he joined in 2017. He previously held the CEO position at Coesia IPS Division and Coesia International (2012-2017). Prior to that, Mattias Perjos was CEO of Flexlink (2006-2016) and held other leading roles within the group which he joined in 1998. A Swedish citizen, Mattias Perjos holds a Master of Science in Industrial Engineering and Management.
“Throughout his career Mattias Perjos led successful healthcare activities and developed strong industrial skills with an international mindset. He will bring a wealth of experience that will be a strong addition to our Board,” said Karl Rotthier, Chief Executive Officer, EUROAPI. “The entire Board of Directors would like to thank Corinne Le Goff for her valuable contribution to the Board and as a member of the Audit committee and wishes her all the best in her new endeavors.”